Two faces of high‐molecular‐weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off

This publication has 72 references indexed in Scilit:

• Urokinase-Type Plasminogen Activator Receptor Is Involved in Mediating the Apoptotic Effect of Cleaved High Molecular Weight Kininogen in Human Endothelial Cells
  Circulation Research, 2004
• Mapping the Interaction between High Molecular Mass Kininogen and the Urokinase Plasminogen Activator Receptor
  Published by Elsevier ,2004
• Combined effect of bradykinin B₂and neurokinin‐1 receptor activation on endothelial cell proliferation in acute synovitis.
  The FASEB Journal, 2004
• Apoptotic effect of cleaved high molecular weight kininogen is regulated by extracellular matrix proteins
  Journal of Cellular Biochemistry, 2003
• Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial Cells
  Journal of Biological Chemistry, 2002
• Human airway smooth muscle cells secrete vascular endothelial growth factor: up‐regulation by bradykinin via a protein kinase C and prostanoid‐dependent mechanism
  The FASEB Journal, 2001
• Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells
  Blood, 2001
• Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5
  The FASEB Journal, 2000
• Inhibition of cell adhesion by high molecular weight kininogen.
  The Journal of cell biology, 1992
• Purification and properties of human low molecular weight kininogen
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982